Global Neurodegenerative Disorder Therapeutics Market
Tamanho do mercado em biliões de dólares
CAGR :
% 
USD
17.30 Billion
USD
26.89 Billion
2024
2032
 Período de previsão |
2025 –2032 |
 Tamanho do mercado (ano base ) | USD 17.30 Billion |
 Tamanho do mercado ( Ano de previsão) | USD 26.89 Billion |
 CAGR |
% |
| Principais participantes do mercado |
|
Global Neurodegenerative Disorder Therapeutics Market Segmentation, By Indication (Multiple sclerosis, Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, Others), Drug Glass (Immunomodulator, Interferons, Decarboxylase Inhibitors, Dopamine Agonists, Others), Route of Administration (Oral, Injection, Transdermal), End- User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Industry Trends and Forecast to 2032
Neurodegenerative Disorder Therapeutics Market Analysis
World Population Prospects predicts that by 2050, there will be 2.1 billion individuals over the age of 60 and that the number of persons over the age of 80 would triple to 425 million. 5.8 million Americans currently have Alzheimer's disease, and by 2050, the figure is expected to reach 14 million, according to the Alzheimer's Association. The market is driven by the rising demand for treatments for neurodegenerative disorders as a result of the incidence of neurodegenerative illnesses among the ageing population.
Neurodegenerative Disorder Therapeutics Market Size
Global neurodegenerative disorder therapeutics market size was valued at USD 17.30 billion in 2024 and is projected to reach USD 26.89 billion by 2032, with a CAGR of 5.67% during the forecast period of 2025 to 2032.
Report Scope and Market Segmentation
|
Attributes |
Neurodegenerative Disorder Therapeutics Key Market Insights |
|
Segmentation |
|
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Key Market Players |
Biogen (U.S.), Merck Sharp & Dohme Corp (U.S.), Novartis AG (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel), Orion Corporation (Finland), UCB S.A. (Belgium), ACADIA Pharmaceuticals Inc. (U.S.), Mitsubishi Chemical Group Corporation (Japan), H. Lundbeck A/S (Denmark), Denali Therapeutics (U.S.), Aquinnah Pharmaceuticals (Japan), Prevail Therapeutics (U.S.), AZTherapies, Inc. (U.S.) |
|
Market Opportunities |
|
Neurodegenerative Disorder Therapeutics Market Definition
A variety of fatal diseases known as "neurodegenerative disorders" predominantly affect the neurons in the human brain and cause the progressive degeneration or death of nerve cells. The field of therapeutics for neurodegenerative disorders focuses on the production and research of medications and treatments that halt or reduce the neurodegenerative processes of illnesses including Parkinson's, Alzheimer's, Huntington's, and other neurodegenerative disorders.
Neurodegenerative Disorder Therapeutics Market Dynamics
Drivers
- Rise in prevalence of neurodegenerative diseases
Increased financing for neurodegenerative disease research is anticipated to boost market expansion. The market for neurodegenerative disorder therapeutics is expected to grow rapidly from 2025 to 2032 as a result of a number of additional factors, including an increase in the prevalence of neurodegenerative diseases, an ageing population, a rise in the risk of neurological disorders like Alzheimer's and Parkinson's disease, and a better understanding of the genetic foundations and molecular pathology of neurodegenerative diseases.
- Increase in elderly population
The market for therapies for neurodegenerative disorders is expanding as the prevalence of these diseases among the world's population rises. The rise in the population of elderly people is attributed to the rise in neurodegenerative illnesses.
Opportunities
The development of novel therapies for neurodegenerative disorders through gene and cell therapies and the massive scope for adoption of neurodegenerative disorders therapeutics in emerging nations will act as opportunities for market growth.
Restraints/Challenges
On the other hand, increasing failure rate of neurodegenerative drugs in clinical trials will obstruct the market's growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the market.
This neurodegenerative disorder therapeutics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the neurodegenerative disorder therapeutics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Neurodegenerative Disorder Therapeutics Market Scope
The neurodegenerative disorder therapeutics market is segmented on the basis of indication, drug glass, route of administration and end- user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Indication
- Multiple sclerosis
- Alzheimer’s Disease
- Parkinson’s Disease
- Huntington’s Disease
- Others
Drug Glass
- Immunomodulator
- Interferons
- Decarboxylase Inhibitors
- Dopamine Agonists
- Others
Route of Administration
- Oral
- Injection
- Transdermal
End- User
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Neurodegenerative Disorder Therapeutics Market Regional Analysis
The neurodegenerative disorder therapeutics market is analyzed and market size insights and trends are provided by country, indication, drug glass, route of administration and end- user as referenced above.
The countries covered in the neurodegenerative disorder therapeutics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the neurodegenerative disorder therapeutics market due to increasing awareness about the neurodegenerative disorder in the region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2025 to 2032 due to the rising health awareness.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Neurodegenerative Disorder Therapeutics Market Share
The neurodegenerative disorder therapeutics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to neurodegenerative disorder therapeutics market.
Neurodegenerative Disorder Therapeutics Market Leaders Operating in the Market Are:
- Biogen (U.S.)
- Merck Sharp & Dohme Corp (U.S.)
- Novartis AG (Switzerland)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Orion Corporation (Finland)
- UCB S.A. (Belgium)
- ACADIA Pharmaceuticals Inc. (U.S.)
- Mitsubishi Chemical Group Corporation (Japan)
- H. Lundbeck A/S (Denmark)
- Denali Therapeutics (U.S.)
- Aquinnah Pharmaceuticals (Japan)
- Prevail Therapeutics (U.S.)
- AZTherapies, Inc. (U.S.)
Latest Developments in Neurodegenerative Disorder Therapeutics Market
- In January 2020, Biogen Inc., an America Biotechnology company acquired a novel clinical stage asset, PF-05251749 along with the applications from Pfizer for USD 75 million
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
